Compound
US8735413B2 · kind B2 · utility
6Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2012 |
| Grant date | May 27, 2014 |
| Priority date | — |
| Expiry date | Aug 3, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound.The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.